Comereski CR - Search Results

1

Didanosine (ddl) and stavudine (d4T): absence of peripheral neurotoxicity in rabbits.

Warner WA, Bregman CL, Comereski CR, Arezzo JC, Davidson TJ, Knupp CA, Kaul S, Durham SK, Wasserman AJ, Frantz JD. Warner WA, et al. Among authors: comereski cr. Food Chem Toxicol. 1995 Dec;33(12):1047-50. doi: 10.1016/0278-6915(95)00078-x. Food Chem Toxicol. 1995. PMID: 8847000

2

Acute cardiotoxicity of nucleoside analogs FddA and FddI in rats.

Comereski CR, Kelly WA, Davidson TJ, Warner WA, Hopper LD, Oleson FB. Comereski CR, et al. Fundam Appl Toxicol. 1993 Apr;20(3):360-4. doi: 10.1006/faat.1993.1046. Fundam Appl Toxicol. 1993. PMID: 8504910

3

BR96-doxorubicin conjugate (BMS-182248) versus doxorubicin: a comparative toxicity assessment in rats.

Comereski CR, Peden WM, Davidson TJ, Warner GL, Hirth RS, Frantz JD. Comereski CR, et al. Toxicol Pathol. 1994 Sep-Oct;22(5):473-88. doi: 10.1177/019262339402200502. Toxicol Pathol. 1994. PMID: 7899776

4

BR96 sFv-PE40 immunotoxin: nonclinical safety assessment.

Haggerty HG, Warner WA, Comereski CR, Peden WM, Mezza LE, Damle BD, Siegall CB, Davidson TJ. Haggerty HG, et al. Among authors: comereski cr. Toxicol Pathol. 1999 Jan-Feb;27(1):87-94. doi: 10.1177/019262339902700116. Toxicol Pathol. 1999. PMID: 10367679 Review.

5

Influence of immunogenicity on the pharmacokinetics of BMS-191352, a Pseudomonas exotoxin immunoconjugate, in rats and dogs.

Damle B, Tay L, Comereski C, Warner W, Kaul S. Damle B, et al. J Pharm Pharmacol. 2000 Jun;52(6):671-8. doi: 10.1211/0022357001774345. J Pharm Pharmacol. 2000. PMID: 10875544

6

In vivo efficacy and toxicity of a single-chain immunotoxin targeted to CD40.

Francisco JA, Schreiber GJ, Comereski CR, Mezza LE, Warner GL, Davidson TJ, Ledbetter JA, Siegall CB. Francisco JA, et al. Among authors: comereski cr. Blood. 1997 Jun 15;89(12):4493-500. Blood. 1997. PMID: 9192773 Free article.

7

Testicular toxicity of N-methyltetrazolethiol cephalosporin analogs in the juvenile rat.

Comereski CR, Bregman CL, Buroker RA. Comereski CR, et al. Fundam Appl Toxicol. 1987 Feb;8(2):280-9. doi: 10.1016/0272-0590(87)90127-8. Fundam Appl Toxicol. 1987. PMID: 3556839

8

Pain on injection and muscle irritation: a comparison of animal models for assessing parenteral antibiotics.

Comereski CR, Williams PD, Bregman CL, Hottendorf GH. Comereski CR, et al. Fundam Appl Toxicol. 1986 Feb;6(2):335-8. doi: 10.1016/0272-0590(86)90248-4. Fundam Appl Toxicol. 1986. PMID: 3699322

9

Single-dose and multiple-dose intravenous toxicity studies of BMY-25282 in rats.

Bregman CL, Comereski CR, Buroker RA, Hirth RS, Madissoo H, Hottendorf GH. Bregman CL, et al. Among authors: comereski cr. Fundam Appl Toxicol. 1987 Jul;9(1):90-109. doi: 10.1016/0272-0590(87)90157-6. Fundam Appl Toxicol. 1987. PMID: 3622965

10

Assessment of dose proportionality, absolute bioavailability, and immunogenicity response of CTLA4Ig (BMS-188667), a novel immunosuppressive agent, following subcutaneous and intravenous administration to rats.

Srinivas NR, Shyu WC, Weiner RS, Warner G, Comereski C, Tay LK, Greene DS, Barbhaiya RH. Srinivas NR, et al. Pharm Res. 1997 Jul;14(7):911-6. doi: 10.1023/a:1012156001831. Pharm Res. 1997. PMID: 9244149

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters